which follows through as they join the main herd.


“Starter feed intake can be an extremely DSM UPDATE ON VITAMIN E


PRODUCTION Royal DSM has announced a maintenance shutdown of its Vitamin E plant in Sisseln, Switzerland during parts of January/ February 2021. This planned maintenance work, originally scheduled for August 2020, has been deferred to the latest possible time in order to secure continuation of supply. The postponement was necessary as the covid-19 crisis and the flooding of the Yangtze river in the Wuhan area delayed the previously announced up-grade and subsequent start-up of the Vitamin E-plant owned by the DSM – Nenter joint venture (Yimante) in China. After a long production interruption, the


start-up at Yimante is now expected by the end of December 2020. Output is planned to gradually ramp-up during the course of 2021 towards the maximum installed nameplate capacity, which is currently 16kt of Vitamin E oil.


DSM expects the Yimante output to


compensate for the volume gap from its plant in Sisseln, Switzerland in Q1/2021 and will do its utmost to honor existing contracts for its valuable customers.


LIVE YEAST SUPPLEMENT SECURES AUTHORISATION FOR USE IN


CALVES UNTIL 2030 Dairy producers welcome an effective tool to improve early life rumen development, as beneficial live yeast supplement, Saccharomyces cerevisiae CNCM I-1077 (Levucell SC), secures authorisation in Europe until 2030. “We’re all aware of how vital the first


few months of life are to securing digestive development in calves, with potential long- term consequences being seen if this isn’t achieved,” explains Mark McFarland, feed additive product manager for Lallemand Animal Nutrition. “Live yeast supplementation is a


fantastic way to ensure youngstock have the best possible start and are able to reach their full growth potential, so we’re really pleased this authorisation has been secured.” The yeast supplement, which has


gained EU authorisation for the use in all calves until 2030, is added to the diet via solid feed before weaning. Due to patented micro-encapsulation technology, the live yeast is proven to survive the pelletisation feed manufacturing process, and is activated when it reaches the calf’s rumen. Mark notes it has been well documented


in numerous trials, that a developed digestive system is essential for youngstock and helps to ensure optimal health and performance,


limiting factor when optimising growth in calves, but trials have demonstrated the positive effect of supplementation on feed intake, with a 20% increase pre weaning and 8% increase post-weaning,” he adds. “In the same trials, higher starter feed


intake also improved growth performance with an average increase of 120g/day, which is the equivalent to 10%.” He comments that the results


demonstrated that this led to more uniformed calves as a group, and meant that target weaning weights were achieved, on average, 1.5 days earlier. “Through extensive trials carried out


by Lallemand Animal Nutrition, we’ve seen the positive impact Levucell SC has on well- being and rumen development, so we’re pleased to have it authorised as an option for farmers to incorporate into calf diets for years to come,” concludes Mark.


AB VISTA PEELS BACK THE LAYERS OF


FIBRE FOR ANIMAL PERFORMANCE WITH


WHITEPAPER AB Vista has published a new whitepaper called ‘Peeling Back the Layers of Fibre for Animal Performance’ which discusses several misconceptions held in the industry about the complex topic of dietary fibre. The whitepaper also explores the potential of NSP (Non Starch Polysaccharides) analysis through NIR (Near Infrared) to bring new insights related to fibre composition, and outlines the tools available today for producers to extract value of the dietary fibre through the modulation of gut microbiome and better performance. The paper follows the release of ‘An


Introduction to Fibre Analysis Using NIR’ in July, which provides NSP values for raw materials and cereals, highlighting the variations. ‘Peeling Back the Layers of Fibre for Animal Performance’ considers the different fibre parameters analysed in the introductory guide explaining what the composition and the variation of the different parameters could potentially mean for producers. AB Vista’s Global Technical Support


Manager, Xavière Rousseau says: “With the cost of soybean meal increasing, a rising pressure to use more local ingredients and a desire to improve gut function we anticipate the level of interest in the fibre fraction is likely to increase. With this in mind, it’s important to develop our knowledge of this topic.


“There is still much to learn and


research in this area, however, through our work with the International Fibre Summit, our NSP analysis service, and unique stimbiotic product Signis we are well positioned to help customers gain a deeper understanding of


PAGE 54 NOVEMBER/DECEMBER 2020 FEED COMPOUNDER


how best to extract the hidden value within fibre to improve productivity.” A free copy of the whitepaper can


be requested from regional AB Vista representatives or downloaded via the AB Vista website:


EVONIK TO CONCENTRATE METAMINO®


PRODUCTION AT


ITS THREE, WORLD-SCALE HUBS Evonik is to cluster its MetAMINO®


(DL-


methionine) production at three international hubs (Americas, Europe, and Asia) to maximize economies of scale and utilize robust processes. Evonik is a leading global manufacturer


of DL-methionine, an essential amino acid which is used in modern feed formulation therefore enabling the company to play a pivotal role in addressing sustainable animal protein supply, food safety and animal welfare. All three of Evonik’s world-scale plants operate along cost


MetAMINO®


leading, best-in-class technology lines, and offer opportunities for further expansion. They are also ready for cost efficient modular debottlenecking in the future. Evonik believes it is now perfectly positioned for future growth at an improved competitive cost position. Following this strategy, Evonik is to close the smallest of its MetAMINO® plants with a


capacity of 65,000 tons per year, located in Wesseling, Germany, by the end of the first quarter, 2021. In addition, Evonik will invest about €25 million into upgrading its world- scale plant for methionine intermediates in Wesseling to safeguard long-term supply to the Antwerp site and to strengthen its European MetAMINO®


-Verbund. This will lead to a better cost position


– through improved utilization of capacity – with economies of scale and an enhanced ability to adapt to any market condition. Dr. Emmanuel Auer, head of Animal


Nutrition business line at Evonik, said: “The methionine business is important for Evonik, now and in the future. We will adapt to market challenges and prepare our asset set-up for highest efficiency and further optimized cost structures. We have engaged in continuous efficiency measures and programs over the past few years. As part of structural asset optimization, the time felt right to close the smallest methionine asset.” In 2014, Evonik opened its methionine


production facility in Singapore. In 2019 the company doubled the nameplate capacity at the site. Today Singapore is the largest DL-methionine production complex in the world with a nameplate capacity of 300,000 tons per year MetAMINO®


; a new industry


standard for efficient, safe and sustainable operation. Alongside Singapore, Evonik operates


world-scale facilities in Mobile, Alabama, USA; and in Antwerp, Belgium. Evonik has been producing MetAMINO® since 1967.


in Wesseling


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68